Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RNA: De-silencing to the rescue.
Held JP, Patel MR. Held JP, et al. Among authors: patel mr. Curr Biol. 2024 Jun 17;34(12):R573-R575. doi: 10.1016/j.cub.2024.05.011. Curr Biol. 2024. PMID: 38889679
CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescent.
Kinney BLC, Brammer B, Kansal V, Parrish CJ, Kissick HT, Liu Y, Saba NF, Buchwald ZS, El-Deiry MW, Patel MR, Boyce BJ, Kaka AS, Gross JH, Baddour HM, Chen AY, Schmitt NC. Kinney BLC, et al. Among authors: patel mr. Oncoimmunology. 2024 Jun 14;13(1):2367777. doi: 10.1080/2162402X.2024.2367777. eCollection 2024. Oncoimmunology. 2024. PMID: 38887372 Free PMC article.
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial.
Roeker LE, Woyach JA, Cheah CYY, Coombs CC, Shah NN, Wierda WG, Patel MR, Lamanna N, Tsai DE, Nair BC, Wang C, Zhao X, Liu D, Radtke D, Chapman S, Marella N, McNeely SC, Brown JR. Roeker LE, et al. Among authors: patel mr. Blood. 2024 Jun 11:blood.2024024510. doi: 10.1182/blood.2024024510. Online ahead of print. Blood. 2024. PMID: 38861666
Frameworks for procurement, integration, monitoring, and evaluation of artificial intelligence tools in clinical settings: A systematic review.
Khan SD, Hoodbhoy Z, Raja MHR, Kim JY, Hogg HDJ, Manji AAA, Gulamali F, Hasan A, Shaikh A, Tajuddin S, Khan NS, Patel MR, Balu S, Samad Z, Sendak MP. Khan SD, et al. Among authors: patel mr. PLOS Digit Health. 2024 May 29;3(5):e0000514. doi: 10.1371/journal.pdig.0000514. eCollection 2024 May. PLOS Digit Health. 2024. PMID: 38809946 Free PMC article.
Framework of the Strengths and Challenges of Clinically Integrated Trials: An Expert Panel Report.
Peters AE, Jones WS, Anderson B, Bramante CT, Broedl U, Hornik CP, Kehoe L, Knowlton KU, Krofah E, Landray M, Locke T, Patel MR, Psotka M, Rockhold FW, Roessig L, Rothman RL, Schofield L, Stockbridge N, Trontell A, Curtis LH, Tenaerts P, Hernandez AF. Peters AE, et al. Among authors: patel mr. Am Heart J. 2024 May 23:S0002-8703(24)00124-8. doi: 10.1016/j.ahj.2024.05.009. Online ahead of print. Am Heart J. 2024. PMID: 38795793
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
Saba NF, Wong SJ, Nasti T, McCook-Veal AA, McDonald MW, Stokes WA, Anderson AM, Ekpenyong A, Rupji M, Abousaud M, Rudra S, Bates JE, Remick JS, Joshi NP, Woody NM, Awan M, Geiger JL, Shreenivas A, Samsa J, Ward MC, Schmitt NC, Patel MR, Higgins KA, Teng Y, Steuer CE, Shin DM, Liu Y, Ahmed R, Koyfman SA. Saba NF, et al. Among authors: patel mr. JAMA Oncol. 2024 May 23:e241143. doi: 10.1001/jamaoncol.2024.1143. Online ahead of print. JAMA Oncol. 2024. PMID: 38780927
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.
Harrington J, Hellkamp AS, Mahaffey KW, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Fox KAA, Singer DE, Goodman SG, Patel MR, Piccini JP. Harrington J, et al. Among authors: patel mr. J Am Heart Assoc. 2024 Jun 4;13(11):e028951. doi: 10.1161/JAHA.122.028951. Epub 2024 May 23. J Am Heart Assoc. 2024. PMID: 38780169 Free article. Clinical Trial.
Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumors.
Chen JJ, Vincent MY, Shepard D, Peereboom D, Mahalingam D, Battiste J, Patel MR, Juric D, Wen PY, Bullock A, Selfridge JE, Pant S, Liu J, Li W, Fyfe S, Wang S, Zota V, Mahoney J, Watnick RS, Cieslewicz M, Watnick J. Chen JJ, et al. Among authors: patel mr. Commun Med (Lond). 2024 May 21;4(1):95. doi: 10.1038/s43856-024-00520-z. Commun Med (Lond). 2024. PMID: 38773224 Free PMC article.
A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results.
Hamilton E, Oliveira M, Turner N, García-Corbacho J, Hernando C, Ciruelos EM, Kabos P, Borrego MR, Armstrong A, Patel MR, Vaklavas C, Twelves C, Boni V, Incorvati J, Brier T, Gibbons L, Klinowska T, Lindemann JPO, Morrow CJ, Sykes A, Baird RD. Hamilton E, et al. Among authors: patel mr. Ann Oncol. 2024 May 8:S0923-7534(24)00138-8. doi: 10.1016/j.annonc.2024.04.012. Online ahead of print. Ann Oncol. 2024. PMID: 38729567 Free article.
1,274 results